European Journal of Pharmaceutics and Biopharmaceutics Citation Rate 2026

ISSN 0939-6411 eISSN 1873-3441 Elsevier BV NL

Q1 Quartile Established Impact

About European Journal of Pharmaceutics and Biopharmaceutics
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

European Journal of Pharmaceutics and Biopharmaceutics (EJPB) is a peer-reviewed academic journal covering Advanced Drug Delivery Systems and Advancements in Transdermal Drug Delivery, published by Elsevier BV in NL, catalogued under ISSN 0939-6411 (e-ISSN 1873-3441). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 4.50 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4270 USD). OpenAlex records 7,000 works and 337,352 citations, with an h-index of 211.

European Journal of Pharmaceutics and Biopharmaceutics Citation Rate 2026 — In Context

European Journal of Pharmaceutics and Biopharmaceutics has a 2025 2-Year Citation Rate (OpenAlex) of 4.50, placing it in the Q1 quartile within the Advanced Drug Delivery Systems research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

European Journal of Pharmaceutics and Biopharmaceutics operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in European Journal of Pharmaceutics and Biopharmaceutics should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare European Journal of Pharmaceutics and Biopharmaceutics against similar journals in the field, use our journal comparison tool.

Submission Tips for European Journal of Pharmaceutics and …
  • Budget $4270 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Advanced Drug Delivery Systems, Advancements in Transdermal Drug Delivery, Drug Solubulity and Delivery Systems. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How European Journal of … Compares
Citation Rate vs Field Avg
-41%
Field avg: 7.67
APC vs Field Avg
+18%
Field avg: $3620

Compared against 26 journals in the same research areas.

ISSN (Print) 0939-6411
ISSN (Online) 1873-3441
Publisher Elsevier BV
Country Netherlands
APC / Cost $4270 USD
In-depth profile & metrics

European Journal of Pharmaceutics and Biopharmaceutics is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4270.

In our subject taxonomy, European Journal of Pharmaceutics and Biopharmaceutics is classified under Advanced Drug Delivery Systems, Advancements in Transdermal Drug Delivery, Drug Solubulity and Delivery Systems and Nanoparticle-Based Drug Delivery.

European Journal of Pharmaceutics and Biopharmaceutics is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 4.498.

Research Areas
Links
Frequently Asked Questions about European Journal of Pharmaceutics and …

European Journal of Pharmaceutics and Biopharmaceutics does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 4.498 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, European Journal of Pharmaceutics and Biopharmaceutics is not an open access journal.

The Article Processing Charge (APC) for European Journal of Pharmaceutics and Biopharmaceutics is $4270 USD.

European Journal of Pharmaceutics and Biopharmaceutics is published by Elsevier BV.

European Journal of Pharmaceutics and Biopharmaceutics shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of European Journal of Pharmaceutics and Biopharmaceutics is 0939-6411. Its electronic ISSN (eISSN) is 1873-3441.

European Journal of Pharmaceutics and Biopharmaceutics sits in the Q1 quartile based on its latest impact factor of 4.50, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
4.498
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 4.498 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S122302516

Get weekly updates for Advanced Drug Delivery Systems journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google